Best Topical Cream for Facial Psoriasis
For facial psoriasis, tacrolimus 0.1% ointment is the recommended first-line topical agent, with calcipotriene combined with low-potency corticosteroids (such as hydrocortisone) as an effective alternative. 1
Primary Recommendation: Topical Calcineurin Inhibitors
Tacrolimus 0.1% ointment is specifically recommended for facial psoriasis because the face is a vulnerable area where higher-potency corticosteroids carry significant risk of skin atrophy and other adverse effects. 1
- Studies demonstrate rapid efficacy, with complete clearance achieved within 72 hours to 2 weeks in facial psoriasis patients. 1
- Tacrolimus is preferred as first-line therapy for psoriasis of the face, genitalia, and body folds according to systematic reviews. 1
- The main side effect is transient burning and stinging at the application site, which is generally well-tolerated. 1
Alternative Option: Vitamin D Analogues with Low-Potency Corticosteroids
Calcipotriene (or tacalcitol) combined with hydrocortisone for 8 weeks is an effective treatment for facial psoriasis (Strength of Recommendation B). 1
- An 8-week RCT demonstrated that calcipotriene combined with hydrocortisone was more effective on facial lesions than calcipotriene alone, with significantly better clearance rates (odds ratio 2.01). 1
- This combination provides anti-inflammatory effects while minimizing the atrophy risk associated with higher-potency steroids on facial skin. 1
Important Caveats for Facial Treatment
Lower potency corticosteroids must be used on the face due to increased susceptibility to steroid-induced atrophy, telangiectasia, and other adverse effects in this anatomically sensitive area. 1
- High- or ultra-high-potency corticosteroids (class 1-2) should be avoided on facial skin. 1
- If corticosteroids are used on the face, limit to low-potency agents (class 6-7) and short durations. 1
Treatment Algorithm for Facial Psoriasis
First-line: Start with tacrolimus 0.1% ointment applied to facial lesions. 1
If tacrolimus causes intolerable burning: Switch to calcipotriene combined with hydrocortisone for 8 weeks. 1
For maintenance: Continue with the agent that achieved clearance, using intermittent application to maintain remission. 1
Avoid: High-potency topical corticosteroids, salicylic acid (which inactivates calcipotriene), and prolonged continuous use of any single agent. 1